Azelis stock: Jefferies cuts rating as leverage limits recovery

Azelis Group N.V. faced a more cautious analyst view on Wednesday, November 11, 2026, when Jefferies cut its rating from Buy to Hold and reduced its price target from 15 euros to 13 euros. The move came as the specialty chemicals and food ingredients distributor continued to show stronger operating momentum but weaker cash conversion.

Investing.com reported that analyst David Kerstens considered moderate, volume-led growth and gradually improving margins largely reflected in the shares after their advance. The analysis also said Azelis shares had fallen 1.7 percent in the market reaction and traded at 10.1 times estimated 2026 EV/EBITA, a 29 percent discount to their historical level.

Growth improves while cash tightens

Azelis reported third-quarter results on October 22, 2026. According to the company's Q3 results release, revenue rose 8.5 percent in constant currency to 1.122 billion euros, with organic growth of 8.2 percent. Adjusted EBITA increased 14.6 percent to 114 million euros, lifting the margin to 10.2 percent.

The recovery required more working capital. Investing.com said free cash flow fell 52 percent to 67 million euros and leverage remained at 3.5 times EBITDA, above the company's target of below 3 times. A 350 million euro non-cash goodwill impairment related to past Americas acquisitions also weighed on reported results.

Guidance remains unchanged

Azelis continues to target positive organic adjusted EBITA growth for the 2026 financial year. Its medium-term objectives include high-single-digit annual adjusted EBITA growth, a doubling of earnings per share by 2031 and a return on capital employed above 11.5 percent.

Azelis stock traded at 12.07 euros on Lang & Schwarz at 17:42 CET on Friday, November 13, 2026.

European investors are also weighing earnings recovery, financing costs and demand across industrial distribution in the current market reports.

More news and analyses on Azelis stock.